Zhiqiang An

17.8k total citations · 5 hit papers
207 papers, 8.2k citations indexed

About

Zhiqiang An is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Zhiqiang An has authored 207 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 42 papers in Radiology, Nuclear Medicine and Imaging and 40 papers in Oncology. Recurrent topics in Zhiqiang An's work include Monoclonal and Polyclonal Antibodies Research (41 papers), Plant Pathogens and Fungal Diseases (26 papers) and Mycorrhizal Fungi and Plant Interactions (25 papers). Zhiqiang An is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (41 papers), Plant Pathogens and Fungal Diseases (26 papers) and Mycorrhizal Fungi and Plant Interactions (25 papers). Zhiqiang An collaborates with scholars based in United States, China and Japan. Zhiqiang An's co-authors include Ningyan Zhang, Kyoji Tsuchikama, James W. Hendrix, Xingzhong Liu, Gerald F. Bills, Xuejun Fan, Tong‐Ming Fu, Xun Gui, Wei Xiong and B. Z. Guo and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Zhiqiang An

201 papers receiving 8.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibody-drug conjugates: recent advances in conjugation and linker chemistries

2016 567 citations Kyoji Tsuchikama, Zhiqiang An profile →
TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function

2018 519 citations Yingjun Zhao, Xilin Wu et al. Neuron profile →
The N501Y spike substitution enhances SARS-CoV-2 infection and transmission

2021 341 citations Zhiqiang Ku, Zhiqiang An et al. profile →
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant

2022 223 citations Zhiqiang Ku, Zhiqiang An et al. profile →
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance

2021 210 citations Chisato M. Yamazaki, Aiko Yamaguchi et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhiqiang An United States	48	2.8k	1.6k	1.4k	1.3k	1.1k	207	8.2k
Nisse Kalkkinen Finland	66	6.5k 2.3×	1.9k 1.2×	2.3k 1.7×	422 0.3×	1.2k 1.1×	226	14.2k
Steffan N. Ho United States	31	9.6k 3.4×	1.6k 1.0×	1.1k 0.8×	710 0.5×	2.2k 2.0×	51	14.6k
Janko Kos Slovenia	57	4.3k 1.5×	2.1k 1.3×	663 0.5×	260 0.2×	1.3k 1.2×	314	10.9k
María A. Juliano Brazil	47	4.8k 1.7×	1.5k 0.9×	473 0.3×	270 0.2×	806 0.7×	376	9.1k
Jeffrey K. Pullen United States	11	6.9k 2.5×	718 0.4×	1.0k 0.8×	559 0.4×	1.3k 1.2×	14	10.4k
Larry R. Pease United States	48	9.3k 3.3×	1.7k 1.0×	1.3k 1.0×	1.5k 1.1×	5.2k 4.7×	189	18.3k
Richard Tizard United States	41	6.1k 2.2×	847 0.5×	829 0.6×	1.2k 0.9×	3.3k 3.0×	56	11.8k
Martin R. Larsen Denmark	59	8.4k 3.0×	955 0.6×	773 0.6×	511 0.4×	882 0.8×	260	13.0k
W. Neal Burnette United States	20	4.9k 1.8×	668 0.4×	565 0.4×	1.1k 0.8×	1.2k 1.1×	36	8.9k
Ueli Gubler United States	39	5.1k 1.8×	2.4k 1.4×	964 0.7×	793 0.6×	7.3k 6.6×	66	14.9k

Countries citing papers authored by Zhiqiang An

Since Specialization

Citations

This map shows the geographic impact of Zhiqiang An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiqiang An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiqiang An more than expected).

Fields of papers citing papers by Zhiqiang An

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiqiang An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiqiang An. The network helps show where Zhiqiang An may publish in the future.

Co-authorship network of co-authors of Zhiqiang An

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiqiang An. A scholar is included among the top collaborators of Zhiqiang An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiqiang An. Zhiqiang An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Mingzhe, et al.. (2025). Brazilin reduces methicillin-resistant Staphylococcus aureus virulence and pathogenicity by decreasing the secretion of the α-hemolysin. Phytomedicine. 140. 156616–156616. 1 indexed citations

Yu, Chao, Jinmei Li, Meihui Zhao, et al.. (2025). Concise Biosynthesis of Antifungal Papulacandins. Journal of the American Chemical Society. 147(11). 9037–9042.

Retnakaran, Ravi, Dawei Bu, Philip W. Connelly, et al.. (2025). Serum endotrophin relates to blood pressure in young South Asian women but not White women: evidence of ethnic variation in its early vascular implications. BMC Cardiovascular Disorders. 25(1). 689–689.

Guo, Hailong, Sha Ha, Jason Botten, et al.. (2024). SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies. Viruses. 16(5). 697–697. 6 indexed citations

Morse, Joshua, Xun Gui, Mi Deng, et al.. (2023). Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML. PubMed. 7(1). 13–27. 3 indexed citations

Espitia, Clara, et al.. (2023). Neuroprotective Agents with Therapeutic Potential for COVID-19. Biomolecules. 13(11). 1585–1585. 8 indexed citations

Ha, Summer Y.Y., Yasuaki Anami, Chisato M. Yamazaki, et al.. (2022). An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 21(9). 1449–1461. 36 indexed citations

Mishra, Ila, Clemens Duerrschmid, Zhiqiang Ku, et al.. (2021). Asprosin-neutralizing antibodies as a treatment for metabolic syndrome. eLife. 10. 35 indexed citations

Yamazaki, Chisato M., Aiko Yamaguchi, Yasuaki Anami, et al.. (2021). Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance. Nature Communications. 12(1). 3528–3528. 210 indexed citations breakdown →

10.

Li, Leike, Weixu Meng, Melanie Horton, et al.. (2019). Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes. PLoS Pathogens. 15(6). e1007716–e1007716. 30 indexed citations

11.

Zhao, Yingjun, Xilin Wu, Xiaoguang Li, et al.. (2018). TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function. Neuron. 97(5). 1023–1031.e7. 519 indexed citations breakdown →

12.

Anami, Yasuaki, Wei Xiong, Xun Gui, et al.. (2017). Enzymatic conjugation using branched linkers for constructing homogeneous antibody–drug conjugates with high potency. Organic & Biomolecular Chemistry. 15(26). 5635–5642. 69 indexed citations

13.

Xia, Lin, Daning Wang, Yuanzhi Chen, et al.. (2016). A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5. Scientific Reports. 6(1). 19042–19042. 14 indexed citations

14.

Gong, Xing, Ali Azhdarinia, Sukhen C. Ghosh, et al.. (2016). LGR5-Targeted Antibody–Drug Conjugate Eradicates Gastrointestinal Tumors and Prevents Recurrence. Molecular Cancer Therapeutics. 15(7). 1580–1590. 84 indexed citations

15.

Zhang, Ningyan, Hui Deng, Xuejun Fan, et al.. (2015). Dysfunctional Antibodies in the Tumor Microenvironment Associate with Impaired Anticancer Immunity. Clinical Cancer Research. 21(23). 5380–5390. 18 indexed citations

16.

Fan, Xuejun, Randall J. Brezski, Hui Deng, et al.. (2014). A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies. Molecular Cancer Therapeutics. 14(3). 681–691. 18 indexed citations

17.

Niu, Qiuhong, Xiaowei Huang, Zhang Lin, et al.. (2010). A Trojan horse mechanism of bacterial pathogenesis against nematodes. Proceedings of the National Academy of Sciences. 107(38). 16631–16636. 108 indexed citations

18.

Zhou, Heather, Chen‐Ni Chin, Margaret Wu, et al.. (2009). Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo. European Journal of Pharmacology. 616(1-3). 346–352. 28 indexed citations

19.

Hrin, Renee, Donna L. Montgomery, Fubao Wang, et al.. (2008). Short Communication: In Vitro Synergy between Peptides or Neutralizing Antibodies Targeting the N- and C-Terminal Heptad Repeats of HIV Type 1 gp41. AIDS Research and Human Retroviruses. 24(12). 1537–1544. 10 indexed citations

20.

Yang, Ying, Ence Yang, Zhiqiang An, & Xingzhong Liu. (2007). Evolution of nematode-trapping cells of predatory fungi of the Orbiliaceae based on evidence from rRNA-encoding DNA and multiprotein sequences. Proceedings of the National Academy of Sciences. 104(20). 8379–8384. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact